SL-401 receives E.U. orphan drug designation for blastic plasmacytoid dendritic cell neoplasm Nov. 3, 2015
EMA CHMP recommends approval of Cosentyx for ankylosing spondylitis and psoriatic arthritis Oct. 26, 2015
Applied Genetic Technologies' gene therapy product receives E.U. orphan drug designation Oct. 26, 2015
Genvoya noninferior to Stribild in phase III studies in treatment-naive adults with HIV infection Oct. 23, 2015
RSS